Regulation (EC) No. 1924/2006 determined that the use of health claims should only be authorised following a high level of scientific validation conducted by EFSA, using appropriate measures in this evaluation. Currently, the legislation only protects consumers but should also define specific health investigation areas with proper outcome measures to evaluate the quality, relevance and adequacy of studies conducted for scientific substantiation of health claims.

This is becoming particularly important for gastroenterology related discomfort where nutritional intervention may lead to positive feedback.

SPRIM is becoming the go-to reference source in gastroenterology clinical programmes. Drawing on our experience and using innovation, we design research services that are successfully managed in the following topics:

  • Bile Acids Recirculation;
  • Antibiotic Associated Diarrhea;
  • Transit Time;
  • IBS (Irritable Bowel Syndrome);
  • IBD (Inflammatory Bowel Disease);
  • Functional Constipation;
  • Functional Abdominal Pain;
  • Traveler’s Diarrhea;
  • Product Tolerability and Digestibility;
  • Microbiota evaluation;
  • Gut Infection;
  • Celiac Disease;
  • Crohn’s Disease.

The gut microbiota plays an important role in health maintenance by performing: metabolic, protective, structural and histological functions. Changes in the balance of gut microbiota can be caused by interactions with a disease, product, therapy or diet.

SPRIM provides tools for assessing the balance of gut flora:

  • Validated methods from faeces collection to analysis;
  • Flora assessment: characterisation of the intestinal microbiome: richness, diversity, evolution, biomarkers and taxonomic classification;
  • Clinical and pre-clinical studies to demonstrate probiotic product efficacy;
  • Nutritional intervention to assess probiotic intake and related effect on gut microbiota.

our publications & case studies

Discover our latest scientific publications